Jonathan Solomon
Chief Executive Officer presso BIOMX INC.
Patrimonio netto: 11 250 $ in data 31/03/2024
Profilo
Jonathan Eithan Solomon is the founder.
He founded Proclara Biosciences, Inc. in 2006 and served as the Chief Executive Officer & Media Relations Contact in 2015.
Currently, he holds the position of Chief Executive Officer & Director at BiomX, Inc. since 2019, Chief Executive Officer & Director at BiomX Ltd.
since 2017, and Director at Solomon Holdings Ltd.
since 2009.
Previously, he worked as a Principal at Medtronic Corp.
Mr. Solomon's education includes a graduate degree from Tel-Aviv University, an undergraduate degree from The Hebrew University of Jerusalem, and an MBA from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOMX INC.
0.05% | 11/12/2023 | 25 000 ( 0.05% ) | 11 250 $ | 31/03/2024 |
Posizioni attive di Jonathan Solomon
| Società | Posizione | Inizio |
|---|---|---|
| BIOMX INC. | Chief Executive Officer | 28/10/2019 |
Solomon Holdings Ltd.
 Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Director/Board Member | 07/03/2013 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chief Executive Officer | 01/05/2017 |
Precedenti posizioni note di Jonathan Solomon
| Società | Posizione | Fine |
|---|---|---|
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Founder | 01/12/2015 |
| Medtronic Corp. | Corporate Officer/Principal | - |
Formazione di Jonathan Solomon
| Tel-Aviv University | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOMX INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
Solomon Holdings Ltd.
Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Finance |
| Medtronic Corp. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
- Borsa valori
- Insiders
- Jonathan Solomon
